|
Immunotherapy
Citations 441-450 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia
- Mohammad-Reza Rezvany, Mahmood Jeddi-Tehrani, Hans Wigzell, Anders Österborg, and Håkan Mellstedt
Blood 2003; 101: 1063-1070.
[Abstract]
[Full text]
[PDF]
CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy
- Carolina Berger, C. Anthony Blau, Tim Clackson, Stanley R. Riddell, and Shelly Heimfeld
Blood 2003; 101: 476-484.
[Abstract]
[Full text]
[PDF]
Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma
- Antonio Curti, Mariella Parenza, and Mario P. Colombo
Blood 2003; 101: 568-575.
[Abstract]
[Full text]
[PDF]
Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma
- Ursula Pertl, Harald Wodrich, J. Michael Ruehlmann, Stephen D. Gillies, Holger N. Lode, and Ralph A. Reisfeld
Blood 2003; 101: 649-654.
[Abstract]
[Full text]
[PDF]
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
- Jagadeesh Bayry, Sébastien Lacroix-Desmazes, Cedric Carbonneil, Namita Misra, Vladimira Donkova, Anastas Pashov, Alain Chevailler, Luc Mouthon, Bernard Weill, Patrick Bruneval, Michel D. Kazatchkine, and Srini V. Kaveri
Blood 2003; 101: 758-765.
[Abstract]
[Full text]
[PDF]
Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy
- Marie-Christine Meunier, Guillaume Roy-Proulx, Nathalie Labrecque, and Claude Perreault
Blood 2003; 101: 766-770.
[Abstract]
[Full text]
[PDF]
Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity
- Hanping Feng, Yi Zeng, Michael W. Graner, Anna Likhacheva, and Emmanuel Katsanis
Blood 2003; 101: 245-252.
[Abstract]
[Full text]
[PDF]
Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells
- Toshiaki Kikuchi, Makoto Maemondo, Koh Narumi, Kunio Matsumoto, Toshikazu Nakamura, and Toshihiro Nukiwa
Blood 2002; 100: 3950-3959.
[Abstract]
[Full text]
[PDF]
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection
- Barbara Savoldo, M. Helen Huls, Zhensheng Liu, Takayuki Okamura, Hans-Dieter Volk, Petra Reinke, Robert Sabat, Nina Babel, James F. Jones, Jennifer Webster-Cyriaque, Adrian P. Gee, Malcolm K. Brenner, Helen E. Heslop, and Cliona M. Rooney
Blood 2002; 100: 4059-4066.
[Abstract]
[Full text]
[PDF]
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells
- Hanping Feng, Yi Zeng, Michael W. Graner, and Emmanuel Katsanis
Blood 2002; 100: 4108-4115.
[Abstract]
[Full text]
[PDF]
|
|
